Chief Executive Officer
General medicine
Mark Pharmaceuties
Romania
Andrew Muddle co-founded MedPharm in August 1999. Dr. Muddle has spent 19 years in the pharmaceutical industry in the drug delivery area and has worked for a number of companies of varying sizes. At PowderJect Pharmaceuticals plc, he was Technical Director (Pharmaceutical Development) with responsibility for pharmaceutical sciences, and both pre-clinical and clinical functions. He held this position for three and a half years and made a major contribution in the early development of the company, as well as being pivotal in the IPO in 1997. Dr. Muddle has managed development projects through to commercialisation of several transdermal patch products. Prior to this, he also held technical positions with drug delivery companies such as the Elan Corporation, Ethical Pharmaceuticals Ltd (U.K.), Controlled Therapeutics (Scotland) and Ciba-Geigy (now Novartis).
pharmaceuticals